Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(2.73)
# 1,932
Out of 4,902 analysts
209
Total ratings
25.47%
Success rate
2%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.19 | +656.30% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.73 | +994.99% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $6.92 | +174.57% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $2.43 | +64.61% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $2.10 | -4.76% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $0.84 | +857.40% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $3.03 | +527.06% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.39 | +778.66% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $2.42 | +519.83% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $56 | $1.27 | +4,309.45% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.28 | +681.25% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.56 | +255.18% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $15.67 | +91.45% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $7.00 | +171.43% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $350 | $1.05 | +33,233.33% | 2 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.74 | +327.81% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.98 | +512.24% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.60 | +6,169.59% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.05 | +1,622.49% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.41 | +729.88% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $7.45 | +211,309.40% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $14.08 | +3,451.14% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $16.16 | +1,385.15% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.97 | +3,960.91% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $0.78 | +12,695.91% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $5.99 | +133,455.93% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.29 | +442.64% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.41 | +1,144.81% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $2.75 | +1,354.55% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $4.17 | +331.65% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.89 | +73.01% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $4.61 | +31,136.44% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $38.89 | -38.29% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $2.33 | +146,681.12% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $2.42 | +785,023.97% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.19
Upside: +656.30%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.73
Upside: +994.99%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $6.92
Upside: +174.57%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $2.43
Upside: +64.61%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $2.10
Upside: -4.76%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $0.84
Upside: +857.40%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $3.03
Upside: +527.06%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.39
Upside: +778.66%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $2.42
Upside: +519.83%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $56
Current: $1.27
Upside: +4,309.45%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $1.28
Upside: +681.25%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.56
Upside: +255.18%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $15.67
Upside: +91.45%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $7.00
Upside: +171.43%
Dec 4, 2024
Reiterates: Neutral
Price Target: $350
Current: $1.05
Upside: +33,233.33%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $3.74
Upside: +327.81%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.98
Upside: +512.24%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.60
Upside: +6,169.59%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $1.05
Upside: +1,622.49%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.41
Upside: +729.88%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $7.45
Upside: +211,309.40%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $14.08
Upside: +3,451.14%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $16.16
Upside: +1,385.15%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.97
Upside: +3,960.91%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $0.78
Upside: +12,695.91%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $5.99
Upside: +133,455.93%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.29
Upside: +442.64%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.41
Upside: +1,144.81%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $2.75
Upside: +1,354.55%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $4.17
Upside: +331.65%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $2.89
Upside: +73.01%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $4.61
Upside: +31,136.44%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $38.89
Upside: -38.29%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $2.33
Upside: +146,681.12%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $2.42
Upside: +785,023.97%